Novartis Unit Settles Shareholder Action For $30M
A federal judge has given his final approval to a $30 million securities class action settlement between Novartis Vaccines & Diagnostic Inc. and its shareholders, bringing to a close five years...To view the full article, register now.
Already a subscriber? Click here to view full article